Journal of Clinical Oncology, Vol 2, 2-7, Copyright © 1984 by American Society of Clinical Oncology

ARTICLES

Gene amplification in a leukemic patient treated with methotrexate

RC Horns Jr, WJ Dower and RT Schimke

Resistance to methotrexate (MTX) has been shown in mouse, hamster, and human cell lines grown in sequentially increased MTX concentrations to be due to increased dihydrofolate reductase (DHFR) synthesis and a proportional increase in DHFR gene copy number. Leukemia cells of a patient were studied to assess change in DHFR gene copy number after MTX treatment. The patient presented with chronic myeloid leukemia which rapidly evolved into blast crisis; 90% of peripheral white cells were lymphoblasts. Treatment included intrathecal and intravenous MTX; the lymphoblasts were reduced to undetectable levels. Three months later a second blast crisis occurred; 90% of peripheral white cells were lymphoblasts. Cells from each blast crisis were obtained by leukapheresis and stored for study. Quantification of DHFR gene copy number in DNA from lymphoblasts before and after MTX treatment was done: a radiolabeled cloned cDNA constituting the mouse DHFR coding sequence was used to probe high molecular weight pretreatment and posttreatment DNA bound to nitrocellulose filters. Posttreatment DNA contained two- to three-fold more DHFR gene sequences than pretreatment DNA. Quantitative Southern blotting of EcoRI-digested pretreatment and posttreatment DNA confirmed amplification of the DHFR gene. Karyotype analysis showed no double minute chromosomes or homogeneously staining regions. This is the first study demonstrating DHFR gene amplification in leukemia cells sampled in vivo from a patient treated with MTX.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				T.-L. Wang, L. A. Diaz Jr., K. Romans, A. Bardelli, S. Saha, G. Galizia, M. Choti, R. Donehower, G. Parmigiani, I.-M. Shih, et al. Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients PNAS, March 2, 2004; 101(9): 3089 - 3094. [Abstract] [Full Text] [PDF]

				J. T. Drummond, J. Genschel, E. Wolf, and P. Modrich DHFR/MSH3 amplification in methotrexate-resistant cells alters the hMutSalpha /hMutSbeta ratio and reduces the efficiency of base-base mismatch repair PNAS, September 16, 1997; 94(19): 10144 - 10149. [Abstract] [Full Text] [PDF]

				L Nicol and P Jeppesen Chromatin organization in the homogeneously staining regions of a methotrexate-resistant mouse cell line: interspersion of inactive and active chromatin domains distinguished by acetylation of histone H4 J. Cell Sci., January 9, 1996; 109(9): 2221 - 2228. [Abstract] [PDF]

				C Ma, S Martin, B Trask, and J L Hamlin Sister chromatid fusion initiates amplification of the dihydrofolate reductase gene in Chinese hamster cells. Genes & Dev., April 1, 1993; 7(4): 605 - 620. [Abstract] [PDF]

				S K Whoriskey, V H Nghiem, P M Leong, J M Masson, and J H Miller Genetic rearrangements and gene amplification in Escherichia coli: DNA sequences at the junctures of amplified gene fusions. Genes & Dev., May 1, 1987; 1(3): 227 - 237. [Abstract] [PDF]